Analysis

Eupraxia Pharmaceuticals, Inc. (EPRX) Stock Analysis

Eupraxia Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to EPRX.

websiteEPRX/analysis/EPRX

Eupraxia Pharmaceuticals, Inc.

Eupraxia Pharmaceuticals, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to EPRX.

Stock profile

Ticker

EPRX

Asset type

Stock

Market cap

$423.7M

Sector

Health Technology

Industry

Biotechnology

Currency

CAD

Ticker listings

Eupraxia Pharmaceuticals, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • EPRX primary listing
  • A3EGRS
  • X43

Latest Eupraxia Pharmaceuticals, Inc. news

Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders

VANCOUVER, British Columbia, June 19, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechno...

Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

VANCOUVER, British Columbia, May 28, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eup...

Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results

Robust response in highest dose cohort after 36 weeks following a single treatment of EP-104GI ...

Eupraxia Pharmaceuticals' First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis ...

EoEHSS (EoE Histology Scoring System) is a standardized method used to monitor esophageal tissue ...

Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease W...

EREFS is a standardized visual scoring system that gastroenterologists use when performing an end...

Research sections

Valuation

Review valuation context for Eupraxia Pharmaceuticals, Inc..

Future growth

Review future growth context for Eupraxia Pharmaceuticals, Inc..

Past performance

Review past performance context for Eupraxia Pharmaceuticals, Inc..

Financial health

Review financial health context for Eupraxia Pharmaceuticals, Inc..

Dividend

Review dividend context for Eupraxia Pharmaceuticals, Inc..

Management

Review management context for Eupraxia Pharmaceuticals, Inc..

Ownership

Review ownership context for Eupraxia Pharmaceuticals, Inc..

Other information

Review other information context for Eupraxia Pharmaceuticals, Inc..

Community

Review community context for Eupraxia Pharmaceuticals, Inc..